IECM
Intrinsic Edge Capital Management’s Castle Biosciences CSTL Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-232,711
| Closed | -$6.2M | – | 72 |
|
|
2024
Q4 | $6.2M | Buy |
232,711
+20,000
| +9% | +$533K | 0.75% | 47 |
|
|
2024
Q3 | $6.07M | Sell |
212,711
-41,700
| -16% | -$1.19M | 0.73% | 42 |
|
|
2024
Q2 | $5.54M | Buy |
254,411
+30,844
| +14% | +$671K | 0.5% | 61 |
|
|
2024
Q1 | $4.95M | Sell |
223,567
-102,703
| -31% | -$2.27M | 0.39% | 73 |
|
|
2023
Q4 | $7.04M | Buy |
326,270
+170,000
| +109% | +$3.67M | 0.7% | 46 |
|
|
2023
Q3 | $2.64M | Sell |
156,270
-199,936
| -56% | -$3.38M | 0.3% | 83 |
|
|
2023
Q2 | $4.89M | Sell |
356,206
-39,630
| -10% | -$544K | 0.35% | 89 |
|
|
2023
Q1 | $8.99M | Buy |
395,836
+30,869
| +8% | +$701K | 0.9% | 50 |
|
|
2022
Q4 | $8.59M | Buy |
364,967
+52,567
| +17% | +$1.24M | 0.86% | 45 |
|
|
2022
Q3 | $8.15M | Buy |
312,400
+30,000
| +11% | +$782K | 0.89% | 43 |
|
|
2022
Q2 | $6.2M | Buy |
282,400
+70,000
| +33% | +$1.54M | 0.48% | 71 |
|
|
2022
Q1 | $9.53M | Buy |
+212,400
| New | +$9.53M | 0.73% | 50 |
|
|
2021
Q4 | – | Sell |
-147,895
| Closed | -$9.84M | – | 183 |
|
|
2021
Q3 | $9.84M | Sell |
147,895
-22,070
| -13% | -$1.47M | 0.68% | 54 |
|
|
2021
Q2 | $12.5M | Buy |
169,965
+129,965
| +325% | +$9.53M | 0.73% | 39 |
|
|
2021
Q1 | $2.74M | Buy |
+40,000
| New | +$2.74M | 0.19% | 169 |
|